ATH 0.00% 0.3¢ alterity therapeutics limited

See What Happens Next, page-11

  1. 1,560 Posts.
    lightbulb Created with Sketch. 2
    tb, Your opinion seems to be that of the slowly-building majority, brought to a head by failure of removal of the PCH and disappointment in the manner in which the AGM was conducted. Perhaps something else in addition to weak administrative leadership is to be considered. Perhaps Shoulson and the Huntington Study Group did the best that they could considering the product with which they had to work. Maybe, just surmising?

    It is odd that only here and another MB that we hear reference to Prana science as the Holy Grail and some do still staunchly remain enamored of "The Science". The Science has had a very long time to prove itself. PBT2 has been studied but unchanged since 2005. Institutions and funds have made no secret of their lack of confidence in The Science and no saleable products by their very anemic 2% ownership. It's a merry-go-round: weak leadership + unproven science + no partnership interest = continued share selling + no therapeutic product to sell. What gives, really?
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $4.579K 1.526M

Buyers (Bids)

No. Vol. Price($)
2 749591 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 133062022 26
View Market Depth
Last trade - 14.03pm 13/09/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.